​

Pyxis Oncology (PYXS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Pyxis Oncology Revenue Highlights

Latest Revenue (Y)

$16.15M

0

Pyxis Oncology Revenue by Period

Pyxis Oncology Revenue by Year

DateRevenueChange
2024-12-31$16.15M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Pyxis Oncology generated $16.15M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Pyxis Oncology Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$2.82M100.00%
2025-03-31--100.00%
2024-12-31$3.40M100.00%
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$16.15M372.11%
2023-12-31$3.42M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Pyxis Oncology generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Pyxis Oncology Revenue Breakdown

Pyxis Oncology Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 25Sep 24Jun 24Mar 24
Milestone Revenue$2.82M---
Royalty-$8.15M$8.15M$8.15M

Pyxis Oncology's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Milestone Revenue (100.00%).

Pyxis Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VYGRVoyager Therapeutics$80.00M$13.37M
ENTAEnanta Pharmaceuticals$67.64M$18.31M
FHTXFoghorn Therapeutics$22.60M$8.15M
PYXSPyxis Oncology$16.15M-
IMRXImmuneering--
ZURAZura Bio--
CRBUCaribou Biosciences--
TNYATenaya Therapeutics--
HUMAHumacyte-$753.00K
AVIRAtea Pharmaceuticals--

PYXS Revenue FAQ

What is Pyxis Oncology’s yearly revenue?

Pyxis Oncology's yearly revenue for 2024 was $16.15M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. PYXS's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Pyxis Oncology’s quarterly revenue?

Pyxis Oncology's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.82M, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). PYXS's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024).

What is Pyxis Oncology’s revenue growth rate?

Pyxis Oncology's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.